FDA Inspection 1038666 — Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc.
The FDA completed an inspection of Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc. on January 11, 2018 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional Details
In Vivo Bioequivalence